Sibel Ada
Research Subjects
Sibel Ada has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Berrak Itır Aylı
School of Life Sceinces, University of Westminster, London W1B 2HW, UK
2 shared publications - Gurkan Yurteri
Hemodialysis Unit Rentek Dialysis Center Istanbul Turkey
2 shared publications Abdurrahman Biçer
Department of Internal Medicine, Van Training and Research Hospital, Van, Türkiye
1 shared publication- Abdurrahman Biçer
Health Sciences University Van Education and Training Hospital
1 shared publication Huseyin Sahinturk
Department of Infectious Disease, Erzincan Mengücek Gazi Training and Research Hospital, Erzincan, Türkiye
1 shared publication- Necmi Eren
Division of Nephrology, Department of Internal Medicine, Kocaeli University Faculty of Medicine, Kocaeli, Türkiye
1 shared publication
Latest Publications
- Open Access
- 21 March 2026
- Published by SAGE Publications in The Journal of Vascular Access
- Vol. 27 (5) , 2062-2070
From algorithms to action: Risk stratification for arteriovenous fistula failure in hemodialysis
Background: Arteriovenous fistula (AVF) is the preferred vascular access for hemodialysis, yet primary failure and early dysfunction remain common, thereby prolonging catheter dependence and increasing costs. Traditional prediction models show limited discrimination, and few studies have combined machine-learning (ML) methods with formal assessment of clinical utility. This study aimed to identify predictors of AVF failure and compare ML models with logistic regression in a Turkish hemodialysis cohort, and to derive a clinical risk score. Methods: In this retrospective study, 385 adults with native AVFs (171 failures, 214 patent) operated between January 2018 and November 2024 were analyzed. Demographic, clinical, and laboratory variables were extracted from electronic records. Standard logistic regression (GLM), penalized logistic regression (LASSO), Random Forest, and XGBoost models were fitted and evaluated using 10-fold cross-validation and an independent test set (75%/25% split). LASSO coefficients were translated into a hand-calculable clinical risk score. Results: Patients with AVF failure were older and had lower BMI, albumin, and creatinine than those with patent accesses. In multivariable logistic regression, higher urea and lower BMI and albumin independently predicted failure. On the test set, AUCs were 0.731 (GLM), 0.876 (LASSO), 0.918 (Random Forest), and 0.884 (XGBoost). Cross-validated mean AUCs ranged from 0.906 (GLM) to 0.950 (XGBoost), with Brier scores 0.079–0.116 and generally good calibration. A 30% risk threshold suggested a clinically reasonable balance between sensitivity and specificity, and decision-curve analysis showed net benefit for all ML models versus treat-all/none. The clinical risk score stratified patients into low (⩽3 points), intermediate (4–7), and high (⩾8) risk. Conclusion: ML models, particularly ensemble methods, showed improved discrimination compared with standard logistic regression for predicting AVF failure and supported a simple, clinically usable risk score for stratified surveillance.
- 21 March 2026
- Published by SAGE Publications in The Journal of Vascular Access
- Vol. 27 (5) , 2062-2070
Open AccessFrom algorithms to action: Risk stratification for arteriovenous fistula failure in hemodialysis
Background: Arteriovenous fistula (AVF) is the preferred vascular access for hemodialysis, yet primary failure and early dysfunction remain common, thereby prolonging catheter dependence and increasing costs. Traditional prediction models show limited discrimination, and few studies have combined machine-learning (ML) methods with formal assessment of clinical utility. This study aimed to identify predictors of AVF failure and compare ML models with logistic regression in a Turkish hemodialysis cohort, and to derive a clinical risk score. Methods: In this retrospective study, 385 adults with native AVFs (171 failures, 214 patent) operated between January 2018 and November 2024 were analyzed. Demographic, clinical, and laboratory variables were extracted from electronic records. Standard logistic regression (GLM), penalized logistic regression (LASSO), Random Forest, and XGBoost models were fitted and evaluated using 10-fold cross-validation and an independent test set (75%/25% split). LASSO coefficients were translated into a hand-calculable clinical risk score. Results: Patients with AVF failure were older and had lower BMI, albumin, and creatinine than those with patent accesses. In multivariable logistic regression, higher urea and lower BMI and albumin independently predicted failure. On the test set, AUCs were 0.731 (GLM), 0.876 (LASSO), 0.918 (Random Forest), and 0.884 (XGBoost). Cross-validated mean AUCs ranged from 0.906 (GLM) to 0.950 (XGBoost), with Brier scores 0.079–0.116 and generally good calibration. A 30% risk threshold suggested a clinically reasonable balance between sensitivity and specificity, and decision-curve analysis showed net benefit for all ML models versus treat-all/none. The clinical risk score stratified patients into low (⩽3 points), intermediate (4–7), and high (⩾8) risk. Conclusion: ML models, particularly ensemble methods, showed improved discrimination compared with standard logistic regression for predicting AVF failure and supported a simple, clinically usable risk score for stratified surveillance.
- Open Access
- 5 January 2026
- Published by Journal of Health Sciences and Medicine in Journal of Health Sciences and Medicine
- Vol. 9 (1) , 221-227
End-organ damage in hypertension: clinical and public health insights from Turkiye
Aims: Hypertension affects 1.3 billion adults globally yet remains substantially underdiagnosed. In Turkiye, national screening programs exist for several conditions, but universal hypertension screening is not implemented despite hypertension being more prevalent than diseases currently screened. Understanding presentation patterns is essential for informing screening policy. This study aimed to assess hypertension severity and end-organ damage at diagnosis and determine whether symptoms or routine clinical variables can identify patients with more severe blood pressure elevation. Methods: This cross-sectional study examined 126 new hypertension patients presenting to a nephrology clinic in Turkiye between August-October 2025. Participants completed 7-day home blood pressure monitoring before treatment initiation. Sociodemographic characteristics, symptoms, comorbidities, anthropometric measurements, and laboratory parameters were collected. Hypertension severity was classified using 2023 ESC/ESH criteria. Associations between blood pressure and clinical variables were examined using correlation analyses and multiple regression models. Results: At diagnosis, mean systolic blood pressure was 159.75±15.74 mmHg and diastolic was 99.01±10.57 mmHg. Over two-thirds (64.3%) presented with grade 2-3 hypertension. Furthermore, 58 patients (46%) had retinopathy, whereas 10 had microalbuminuria and 11 had left ventricular hypertrophy and 69 (54.7%) presented with insulin resistance as calculated by HOMA-IR scores. Almost all patients (92.8%) reported symptoms, most commonly headache (88.1%) and tinnitus (46.8%), yet symptom burden showed no correlation with blood pressure levels (p>0.05). Several biochemical markers showed weak univariable correlations with blood pressure, but none remained significant in multivariable models. Mean BMI was 31.37±6.10 kg/m², with laboratory findings suggesting increased cardiometabolic risk. Conclusion: Relatively young adults are being diagnosed with hypertension only after years of silent damage, presenting with moderate-to-severe disease and coexisting cardiometabolic abnormalities in addition to potential signs of end-organ damage; mainly retinopathy. Symptoms cannot guide detection, and clinical variables cannot identify high-risk individuals. This late diagnosis perpetuates preventable cardiovascular morbidity, mortality, end-organ damage and escalating healthcare costs. Systematic, population-based blood pressure screening is urgently needed to interrupt this trajectory of invisible harm.
- 5 January 2026
- Published by Journal of Health Sciences and Medicine in Journal of Health Sciences and Medicine
- Vol. 9 (1) , 221-227
Open AccessEnd-organ damage in hypertension: clinical and public health insights from Turkiye
Aims: Hypertension affects 1.3 billion adults globally yet remains substantially underdiagnosed. In Turkiye, national screening programs exist for several conditions, but universal hypertension screening is not implemented despite hypertension being more prevalent than diseases currently screened. Understanding presentation patterns is essential for informing screening policy. This study aimed to assess hypertension severity and end-organ damage at diagnosis and determine whether symptoms or routine clinical variables can identify patients with more severe blood pressure elevation. Methods: This cross-sectional study examined 126 new hypertension patients presenting to a nephrology clinic in Turkiye between August-October 2025. Participants completed 7-day home blood pressure monitoring before treatment initiation. Sociodemographic characteristics, symptoms, comorbidities, anthropometric measurements, and laboratory parameters were collected. Hypertension severity was classified using 2023 ESC/ESH criteria. Associations between blood pressure and clinical variables were examined using correlation analyses and multiple regression models. Results: At diagnosis, mean systolic blood pressure was 159.75±15.74 mmHg and diastolic was 99.01±10.57 mmHg. Over two-thirds (64.3%) presented with grade 2-3 hypertension. Furthermore, 58 patients (46%) had retinopathy, whereas 10 had microalbuminuria and 11 had left ventricular hypertrophy and 69 (54.7%) presented with insulin resistance as calculated by HOMA-IR scores. Almost all patients (92.8%) reported symptoms, most commonly headache (88.1%) and tinnitus (46.8%), yet symptom burden showed no correlation with blood pressure levels (p>0.05). Several biochemical markers showed weak univariable correlations with blood pressure, but none remained significant in multivariable models. Mean BMI was 31.37±6.10 kg/m², with laboratory findings suggesting increased cardiometabolic risk. Conclusion: Relatively young adults are being diagnosed with hypertension only after years of silent damage, presenting with moderate-to-severe disease and coexisting cardiometabolic abnormalities in addition to potential signs of end-organ damage; mainly retinopathy. Symptoms cannot guide detection, and clinical variables cannot identify high-risk individuals. This late diagnosis perpetuates preventable cardiovascular morbidity, mortality, end-organ damage and escalating healthcare costs. Systematic, population-based blood pressure screening is urgently needed to interrupt this trajectory of invisible harm.
- 4 December 2025
- Published by Elsevier in Journal of Renal Nutrition
- Vol. 36 (3) , 511-519
The Impact of a Major Earthquake on Nutritional Status and Survival in Hemodialysis Patients: A Retrospective Observational Study
- 4 December 2025
- Published by Elsevier in Journal of Renal Nutrition
- Vol. 36 (3) , 511-519
The Impact of a Major Earthquake on Nutritional Status and Survival in Hemodialysis Patients: A Retrospective Observational Study
- Open Access
- 25 October 2025
- Published by Journal of Health Sciences and Medicine in Journal of Health Sciences and Medicine
- Vol. 8 (6) , 1055-1059
Novel GLA mutation in a high-consanguinity region: insights from Fabry disease screening in Turkiye
Aims: Fabry disease (FD) is an X-linked lysosomal storage disorder caused by deficient α-galactosidase A (α-Gal A) activity, leading to the accumulation of globotriaosylceramide in multiple organ systems. Its early diagnosis remains a challenge, particularly in high-risk populations. This study aimed to determine the prevalence of FD among hemodialysis patients in Eastern and Southeastern Turkiye, regions with a high rate of consanguineous marriages. Methods: Between 2015 and 2019, 613 adult patients undergoing maintenance hemodialysis across five provinces were screened for α-Gal A activity using dried blood spot testing. Patients with reduced enzyme levels underwent confirmatory testing through leukocyte enzyme assays and GLA gene sequencing. Results: Reduced α-Gal A activity was identified in 15.7% of patients. Genetic analysis in 58 individuals revealed no mutations in males. However, two unrelated female patients were found to carry the same GLA gene variant, c.116C>A (p.T39K), which has not been previously reported in gnomAD or ClinVar databases. The overall prevalence of genetically confirmed FD in this cohort was 0.32%. Conclusion: This is the first regional screening study of FD in Eastern and Southeastern Turkiye. The identification of a novel GLA mutation in a high-consanguinity population underscores the importance of genetic screening in dialysis patients and highlights the need for region-specific diagnostic and counseling strategies.
- 25 October 2025
- Published by Journal of Health Sciences and Medicine in Journal of Health Sciences and Medicine
- Vol. 8 (6) , 1055-1059
Open AccessNovel GLA mutation in a high-consanguinity region: insights from Fabry disease screening in Turkiye
Aims: Fabry disease (FD) is an X-linked lysosomal storage disorder caused by deficient α-galactosidase A (α-Gal A) activity, leading to the accumulation of globotriaosylceramide in multiple organ systems. Its early diagnosis remains a challenge, particularly in high-risk populations. This study aimed to determine the prevalence of FD among hemodialysis patients in Eastern and Southeastern Turkiye, regions with a high rate of consanguineous marriages. Methods: Between 2015 and 2019, 613 adult patients undergoing maintenance hemodialysis across five provinces were screened for α-Gal A activity using dried blood spot testing. Patients with reduced enzyme levels underwent confirmatory testing through leukocyte enzyme assays and GLA gene sequencing. Results: Reduced α-Gal A activity was identified in 15.7% of patients. Genetic analysis in 58 individuals revealed no mutations in males. However, two unrelated female patients were found to carry the same GLA gene variant, c.116C>A (p.T39K), which has not been previously reported in gnomAD or ClinVar databases. The overall prevalence of genetically confirmed FD in this cohort was 0.32%. Conclusion: This is the first regional screening study of FD in Eastern and Southeastern Turkiye. The identification of a novel GLA mutation in a high-consanguinity population underscores the importance of genetic screening in dialysis patients and highlights the need for region-specific diagnostic and counseling strategies.
- 1 August 2024
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 15 (8) , 523-525
Proteinuria in brucellosis: is it related to kidney involvement or fever?
Aim Brucellosis is a zoonotic disease caused by Brucella species. Brucella can invade directly the kidney and cause tubule-interstitial injury, abscesses, and granulomatous formation. In this study, we aim to assess the factors that might have an impact on proteinuria development in brucellosis. Methods This is a prospective self-control study. The individuals who were diagnosed with Brucella infection between March 2019 and March 2021 were enrolled in the study. Clinical and laboratory features of the participants were noted. The urine protein creatinine ratio (UPro/UCre) that estimates the 24-hour protein excretion in grams per day was detected before and after the 45-day treatment. Urinary cultures were performed in all patients if the patients had pyuria. Results Eighty-seven patients were enrolled in the study. The mean age was 33 ± 18 years. Fifty-two of the patients were male (59.8%). Seven of the patients (8%) had urinary system symptoms (8%). None of the urinary cultures were found to be positive for any microorganism. UPro/UCre was 407 ± 328 before treatment and 251 ± 155 after treatment (P = .003). When correlation analysis was made, proteinuria before treatment was found to be correlated with Brucella titer (r = 0.273, P = .03) and body temperature (r = 0.387; P = .04). Conclusion Brucella is a common zoonotic infection that may present with proteinuria in addition to its classic symptoms. The disappearance of proteinuria with antibiotic treatment and the correlation of proteinuria with fever suggest that fever is the leading cause.
- 1 August 2024
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 15 (8) , 523-525
Proteinuria in brucellosis: is it related to kidney involvement or fever?
Aim Brucellosis is a zoonotic disease caused by Brucella species. Brucella can invade directly the kidney and cause tubule-interstitial injury, abscesses, and granulomatous formation. In this study, we aim to assess the factors that might have an impact on proteinuria development in brucellosis. Methods This is a prospective self-control study. The individuals who were diagnosed with Brucella infection between March 2019 and March 2021 were enrolled in the study. Clinical and laboratory features of the participants were noted. The urine protein creatinine ratio (UPro/UCre) that estimates the 24-hour protein excretion in grams per day was detected before and after the 45-day treatment. Urinary cultures were performed in all patients if the patients had pyuria. Results Eighty-seven patients were enrolled in the study. The mean age was 33 ± 18 years. Fifty-two of the patients were male (59.8%). Seven of the patients (8%) had urinary system symptoms (8%). None of the urinary cultures were found to be positive for any microorganism. UPro/UCre was 407 ± 328 before treatment and 251 ± 155 after treatment (P = .003). When correlation analysis was made, proteinuria before treatment was found to be correlated with Brucella titer (r = 0.273, P = .03) and body temperature (r = 0.387; P = .04). Conclusion Brucella is a common zoonotic infection that may present with proteinuria in addition to its classic symptoms. The disappearance of proteinuria with antibiotic treatment and the correlation of proteinuria with fever suggest that fever is the leading cause.
- 12 March 2023
- Published by SAGE Publications in The Journal of Vascular Access
- Vol. 25 (4) , 1279-1284
Malnutrition: A risk factor for vascular access problems
Background: Vascular access problems are leading causes of morbidity, hospitalization, and impaired quality of life in chronic hemodialysis patients. Native arteriovenous fistula is the gold standard of vascular access. Geriatric nutritional risk index (GNRI), has recently been shown to be an easy and objective instrument for assessing nutritional status in these patient groups. Considering the association between arteria-venous fistula patency and inflammation, as well as the fact that inflammation is a component of malnutrition, the objective of this study was to determine the relation of malnutrition identified by GNRI with fistula patency. Methods: This is a single-center, retrospective, observational study. Hemodialysis patients with AVF were included in the research. Preoperative and postoperative GNRI values were computed and laboratory data were recorded. The patients were analyzed in two groups as the ones without thrombosis history (Group 1) and with thrombosis history (Group 2). According to GNRI, patients were investigated in four groups: G0 (non-risk group, >98), G1 (low risk, 92–98), G2 (moderate risk, 82–91), and G3 (high risk, 82). Results: Of the 331 patients, 60.1% (199) were male and the average age was 55 ± 15 years. Preoperative GNRI levels were significantly higher in group 1. In correlation analysis, patency time was positively correlated with preoperative GNRI values. Among the preoperative GNRI groups, the G3 group had a patency duration of 6 months (4.9–7.04), whereas the G0 group had a patency length of 37.59 (35.5–39.65) months. By linear regression analysis, preoperative GNRI and postoperative albumin level were determined to be the significant indicators of patency time. Conclusion: GNRI a new tool for detecting malnutrition was strongly associated with fistula patency in hemodialysis patients. Detection of malnutrition before fistula operation may be helpful for the future follow up of the patients in terms of fistula patency.
- 12 March 2023
- Published by SAGE Publications in The Journal of Vascular Access
- Vol. 25 (4) , 1279-1284
Malnutrition: A risk factor for vascular access problems
Background: Vascular access problems are leading causes of morbidity, hospitalization, and impaired quality of life in chronic hemodialysis patients. Native arteriovenous fistula is the gold standard of vascular access. Geriatric nutritional risk index (GNRI), has recently been shown to be an easy and objective instrument for assessing nutritional status in these patient groups. Considering the association between arteria-venous fistula patency and inflammation, as well as the fact that inflammation is a component of malnutrition, the objective of this study was to determine the relation of malnutrition identified by GNRI with fistula patency. Methods: This is a single-center, retrospective, observational study. Hemodialysis patients with AVF were included in the research. Preoperative and postoperative GNRI values were computed and laboratory data were recorded. The patients were analyzed in two groups as the ones without thrombosis history (Group 1) and with thrombosis history (Group 2). According to GNRI, patients were investigated in four groups: G0 (non-risk group, >98), G1 (low risk, 92–98), G2 (moderate risk, 82–91), and G3 (high risk, 82). Results: Of the 331 patients, 60.1% (199) were male and the average age was 55 ± 15 years. Preoperative GNRI levels were significantly higher in group 1. In correlation analysis, patency time was positively correlated with preoperative GNRI values. Among the preoperative GNRI groups, the G3 group had a patency duration of 6 months (4.9–7.04), whereas the G0 group had a patency length of 37.59 (35.5–39.65) months. By linear regression analysis, preoperative GNRI and postoperative albumin level were determined to be the significant indicators of patency time. Conclusion: GNRI a new tool for detecting malnutrition was strongly associated with fistula patency in hemodialysis patients. Detection of malnutrition before fistula operation may be helpful for the future follow up of the patients in terms of fistula patency.
- 1 January 2023
- Published by Bayt Publications in The Turkish Journal of Geriatrics
- Vol. 26 (4) , 386-393
Systemic immune inflammation index and neutrophil to albumin ratio can predict left ventricular hypertrophy in geriatric hemodialysis patients
Introduction: A link exists between inflammation and left ventricular hypertrophy, which is a risk factor for cardiovascular disease in patients with end-stage renal failure. Neutrophil, lymphocyte, and platelet counts are used to calculate the systemic immune inflammation index. To calculate the neutrophil to albumin ratio, we divided the total number of neutrophils by the albumin concentration. Some articles have illustrated the value of systemic immune inflammation index and neutrophil to albumin ratio for diagnosing disorders associated with inflammation. The purpose of this study was to investigate whether a connection exists between left ventricular hypertrophy and inflammation, as measured by systemic immune inflammation index and neutrophil to albumin ratio, in hemodialysis patients aged >65 years. Materials and Method: This study included 51 patients who had been receiving HD for at least three months. Test results and echocardiography measurements were obtained from patient files. Results: Average patient age was 72.88±5.12 years. Patients were divided into two groups based on left ventricular hypertrophy status. C reactive protein, systemic immune inflammation index and neutrophil to albumin ratio were considerably lower in the left ventricular hypertrophy (-) group, and multivariate logistic regression analysis revealed that high neutrophil to albumin ratio was an independent predictor of left ventricular hypertrophy (odds ratio [OR]:8.83, 95 percent confidence interval [CI]:1.32-28.83, P .0005), in conjunction with a high C reactive protein level (OR:3.45, 95 percent CI:1.905-6.645, P .005). Conclusion: Neutrophil to albumin ratio correlates with C-reactive protein and left ventricular hypertrophy, thereby predicting the inflammation characteristic of left ventricular hypertrophy. Keywords: Inflammation; Hypertrophy, Left Ventricular; Renal Dialysis.
- 1 January 2023
- Published by Bayt Publications in The Turkish Journal of Geriatrics
- Vol. 26 (4) , 386-393
Systemic immune inflammation index and neutrophil to albumin ratio can predict left ventricular hypertrophy in geriatric hemodialysis patients
Introduction: A link exists between inflammation and left ventricular hypertrophy, which is a risk factor for cardiovascular disease in patients with end-stage renal failure. Neutrophil, lymphocyte, and platelet counts are used to calculate the systemic immune inflammation index. To calculate the neutrophil to albumin ratio, we divided the total number of neutrophils by the albumin concentration. Some articles have illustrated the value of systemic immune inflammation index and neutrophil to albumin ratio for diagnosing disorders associated with inflammation. The purpose of this study was to investigate whether a connection exists between left ventricular hypertrophy and inflammation, as measured by systemic immune inflammation index and neutrophil to albumin ratio, in hemodialysis patients aged >65 years. Materials and Method: This study included 51 patients who had been receiving HD for at least three months. Test results and echocardiography measurements were obtained from patient files. Results: Average patient age was 72.88±5.12 years. Patients were divided into two groups based on left ventricular hypertrophy status. C reactive protein, systemic immune inflammation index and neutrophil to albumin ratio were considerably lower in the left ventricular hypertrophy (-) group, and multivariate logistic regression analysis revealed that high neutrophil to albumin ratio was an independent predictor of left ventricular hypertrophy (odds ratio [OR]:8.83, 95 percent confidence interval [CI]:1.32-28.83, P .0005), in conjunction with a high C reactive protein level (OR:3.45, 95 percent CI:1.905-6.645, P .005). Conclusion: Neutrophil to albumin ratio correlates with C-reactive protein and left ventricular hypertrophy, thereby predicting the inflammation characteristic of left ventricular hypertrophy. Keywords: Inflammation; Hypertrophy, Left Ventricular; Renal Dialysis.
- 1 January 2023
- Published by Bolu Abant Izzet Baysal Universitesi, Tip Fakultesi, Abant Tip Dergisi in Abant Medical Journal
- Vol. 12 (2) , 1-2
Dialyzers as a cause of Hemolysis
Objective: Hemolysis is a rare adverse effect of hemodialysis. ıt is induced by chemical pollution, heat, or mechanical harm to clogged hemodialysis lines. Lactate dehydrogenase transforms pyruvate to lactate in the absence of oxygen to make energy. LDH serum levels are raised due to tissue breakdown. A number of clinical illnesses, such as hemolytic disorders, are associated with high serum LDH. Both the Rexeed and Leoceed dialyzers are made by AsahiKASEI. They had the same membrane architecture and permeability, but blood entry angle, chamber length, and hole count varied. The aim of this study is to examine if dialyzer design affects hemolysis. Materials and Methods: A total of 142 patients who were chronically undergoing hemodialysis therapy at the ……………….for a total of 12 hours per week were included. A retrospective examination of the patients was performed. The pre-HD and post-HD LDH levels of individuals who had undergone hemodialysis with both dialyzers during separate sessions of hemodialysis were compared. Results: A hundred forty two patients (63% female) on hemodialysis (HD) treatment were enrolled in the study. Twenty eight patients (20%) had diabetes, 45 had hypertension (32%) and 16 had ischemic heart disease (11%) as a comorbid condition. When LDH difference is compared between groups Leoceed dialyzer group) had statistically significantly higher LDH difference when compared with Rexeed dialyzer group (49.1±20 U/l vs229.8±24.45 U/l;p=0.008). (Table 2). Conclusion: It is possible that the design of the dialyzer contributes in some way to the cell damage that is caused by the larger serum LDH increase in the Leoceed dialyzer. In order to carry out corrective studies on dialyzer design, it would be helpful to analyze the impact of dialyzer design on cell damage using a larger series of patients.
- 1 January 2023
- Published by Bolu Abant Izzet Baysal Universitesi, Tip Fakultesi, Abant Tip Dergisi in Abant Medical Journal
- Vol. 12 (2) , 1-2
Dialyzers as a cause of Hemolysis
Objective: Hemolysis is a rare adverse effect of hemodialysis. ıt is induced by chemical pollution, heat, or mechanical harm to clogged hemodialysis lines. Lactate dehydrogenase transforms pyruvate to lactate in the absence of oxygen to make energy. LDH serum levels are raised due to tissue breakdown. A number of clinical illnesses, such as hemolytic disorders, are associated with high serum LDH. Both the Rexeed and Leoceed dialyzers are made by AsahiKASEI. They had the same membrane architecture and permeability, but blood entry angle, chamber length, and hole count varied. The aim of this study is to examine if dialyzer design affects hemolysis. Materials and Methods: A total of 142 patients who were chronically undergoing hemodialysis therapy at the ……………….for a total of 12 hours per week were included. A retrospective examination of the patients was performed. The pre-HD and post-HD LDH levels of individuals who had undergone hemodialysis with both dialyzers during separate sessions of hemodialysis were compared. Results: A hundred forty two patients (63% female) on hemodialysis (HD) treatment were enrolled in the study. Twenty eight patients (20%) had diabetes, 45 had hypertension (32%) and 16 had ischemic heart disease (11%) as a comorbid condition. When LDH difference is compared between groups Leoceed dialyzer group) had statistically significantly higher LDH difference when compared with Rexeed dialyzer group (49.1±20 U/l vs229.8±24.45 U/l;p=0.008). (Table 2). Conclusion: It is possible that the design of the dialyzer contributes in some way to the cell damage that is caused by the larger serum LDH increase in the Leoceed dialyzer. In order to carry out corrective studies on dialyzer design, it would be helpful to analyze the impact of dialyzer design on cell damage using a larger series of patients.